Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis?

被引:11
|
作者
Dantas, Ana Paula V. [1 ]
Sandberg, Kathryn [1 ]
机构
[1] Georgetown Univ, Ctr Study Sex Differences Hlth Aging & Dis, Washington, DC 20057 USA
关键词
D O I
10.1161/01.RES.0000236802.00855.cd
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:234 / 237
页数:4
相关论文
共 50 条
  • [31] DOES HORMONE REPLACEMENT THERAPY CAUSE DEPENDENCE
    GRIFFITHS, F
    LANCET, 1995, 345 (8943): : 196 - 197
  • [32] 2-Methoxyestradiol Induces Apoptosis of Pulmonary Microvascular Endothelial Cells: A Potential Therapy for Pulmonary Hypertension
    Sweeney, Lori
    JOURNAL OF WOMENS HEALTH, 2008, 17 (08) : 1238 - 1238
  • [33] Novel therapy with 2-methoxyestradiol (2ME2) for the treatment of relapsed and plateau phase multiple myeloma
    Lacy, M.
    Richardson, P.
    Gertz, M.
    Dispenzieri, A.
    Greipp, P.
    Witzig, T.
    Schlossman, R.
    Sidor, C.
    Anderson, K.
    Rajkumar, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] Hormone replacement therapy and coronary artery atherosclerosis: The monkey model
    Clarkson, TB
    Anthony, MS
    Klein, KP
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1996, 103 : 53 - 57
  • [35] Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization
    Sun, Moran
    Zhang, Yixin
    Qin, Jinling
    Ba, Mengyu
    Yao, Yongfang
    Duan, Yongtao
    Liu, Hongmin
    Yu, Dequan
    BIOORGANIC CHEMISTRY, 2021, 113
  • [36] Hormone replacement therapy: a new scare
    不详
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1328 - 1328
  • [37] High oral bioavailability of 2-methoxyestradiol in PEG-PLGA micelles-microspheres for cancer therapy
    Guo, XinHong
    Chen, CaiPing
    Liu, Xin
    Hou, PanPan
    Guo, XiaoNan
    Ding, Fang
    Wang, ZhiHao
    Hu, YuRong
    Li, Zhi
    Zhang, ZhenZhong
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 117 : 116 - 122
  • [38] Novel therapy with 2-methoxyestradiol (2ME2) for the treatment of relapsed and plateau phase multiple myeloma.
    Rajkumar, SV
    Richardson, PG
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Greipp, PR
    Witzig, TE
    Schlossman, RL
    Sidor, C
    Anderson, KC
    BLOOD, 2003, 102 (11) : 692A - 692A
  • [39] Hormone replacement therapy - does route of administration matter?
    Tkaczuk-Wlach, Joanna
    Sobstyl, Malgorzata
    Wlach, Rafal
    Jakiel, Grzegorz
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2013, 12 (06): : 504 - 508
  • [40] Does a hormone replacement therapy influence skin ageing?
    Sator, PG
    Schmidt, JB
    Sator, MO
    Huber, JC
    Hönigsmann, H
    EXPERIMENTAL DERMATOLOGY, 2003, 12 (03) : 333 - 333